0001437749-19-024841.txt : 20191223 0001437749-19-024841.hdr.sgml : 20191223 20191223205403 ACCESSION NUMBER: 0001437749-19-024841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191219 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeMaitre George W CENTRAL INDEX KEY: 0001365737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 191307900 MAIL ADDRESS: STREET 1: 342 BUNKER HILL STREET, #2B CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0306 4 2019-12-19 0001158895 LEMAITRE VASCULAR INC LMAT 0001365737 LeMaitre George W C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 1 Chairman and CEO Common Stock 2019-12-19 4 M 0 17 0 A 2980450 D Common Stock 2019-12-19 4 F 0 691 35.83 D 2979759 D Common Stock 2019-12-20 4 A 0 5109 0 A 2984868 D Common Stock 34962 I See footnote Dividend Equivalent Rights 2019-12-19 4 M 0 17 0 D Common Stock 17 68 D Stock Option (Right to Buy) 35.48 2019-12-20 4 A 0 43050 0 A 2019-12-20 2026-12-20 Common Stock 43050 43050 D Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. These shares are owned by LeMaitre Family LLC. A trust for the benefit of the Reporting Person holds a 20% membership interest in LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by Peter Boland, as trustee for various trusts formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. LeMaitre Family LLC currently holds 174,812 shares of the Issuer's Common Stock. The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. The exercise price of this option to the extent it is an incentive stock option is $39.03 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $35.48 per share. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. The expiration date of this option to the extent it is an incentive stock option is 12/20/2024, and the expiration date of this option to the extent it is a nonqualified stock option is 12/20/2026. /s/ Laurie A. Churchill, Attorney-in-fact 2019-12-23